THERANEXUS: THERANEXUS UNVEILS ITS SCIENTIFIC ADVANCES ON THE OCCASION OF WORLD RARE DISEASE DAY 2022

· New milestone for NeuroLead, the active agent screening platform · New publications in scientific journals · Start of Phase I/II clinical trial for Batten disease
Lyon, 28 February 2022 -

Related Keywords

Paris ,France General ,France ,Verlhac ,Midi Pyrées ,Portejoie ,Haute Normandie ,French ,Anselme Perrier ,Nathalie Rouach ,Mathieu Charv ,Philippe Hantraye ,Development Projects For Competitiveness ,Bpifrance Structuring Research ,Jacob Institute Of Biology ,Twitter ,Drug Development Technologies ,French National Institute Of Health ,Atomic Energy Commission ,Interdisciplinary Research In Biology ,France Center ,National Centre For Scientific Research ,International Journal Of Molecular Sciences ,National Infrastructure In Biology ,Molecular Imaging Research Center Mircen ,World Rare Disease Day ,French Alternative Energies ,Bpifrance Rd Innovation Loan ,Chief Scientific Officer ,Interdisciplinary Research ,Jacob Institute ,Molecular Imaging Research Center ,International Journal ,Molecular Sciences ,Targeting Neuroglial Interactions ,Human Pluripotent Stem Cell ,Identify Modulators ,Transcription Factor ,Structuring Research ,Development Projects ,Euronext Growth ,National Centre ,Scientific Research ,French National Institute ,Medical Research ,National Infrastructure ,Theranexus ,Nveils ,Cientific ,Advances ,Occasion ,World ,Mare ,Disease ,022 ,